The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of rilimogene galvacirepvec/rilimogene glafolivec on intra/peritumoral immune infiltrate in patients with localized prostate cancer undergoing radical prostatectomy.
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); EMD Serono (Inst); NantBioScience (Inst); Pfizer (Inst)
 
Houssein Abdul Sater
No Relationships to Disclose
 
Jenn Marte
No Relationships to Disclose
 
Renee Nicole Donahue
No Relationships to Disclose
 
Beatriz Walter Rodriguez
No Relationships to Disclose
 
Christopher Ryan Heery
Employment - Bavarian Nordic
Leadership - Bavarian Nordic
Stock and Other Ownership Interests - Bavarian Nordic
Honoraria - MPM Capital
Consulting or Advisory Role - MPM Capital
Travel, Accommodations, Expenses - Bavarian Nordic; MPM Capital
 
Mark Stern
Employment - HTG Molecular Diagnostics
Stock and Other Ownership Interests - HTG Molecular Diagnostics
Patents, Royalties, Other Intellectual Property - HTG Molecular Diagnostics
 
Debrah Thompson
Employment - HTG Molecular Diagnostics
Stock and Other Ownership Interests - HTG Molecular Diagnostics
Patents, Royalties, Other Intellectual Property - Author on patents held by HTG Molecular Diagnostics, Inc.
 
Lisa M. Cordes
No Relationships to Disclose
 
Guinevere Chun
No Relationships to Disclose
 
Fatima Karzai
No Relationships to Disclose
 
Marijo Bilusic
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon
Research Funding - Ambry Genetics (Inst); Bavarian Nordic (Inst); Johnson & Johnson (Inst); Sotio (Inst)
 
Jeffrey Schlom
Research Funding - Bavarian Nordic (Inst)
Patents, Royalties, Other Intellectual Property - If applicable; If applicable (Inst)
 
William L. Dahut
No Relationships to Disclose
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)
 
Peter A. Pinto
No Relationships to Disclose